Cited by 166Protein Kinase Regulation and GTPase SignalingCancer-related Molecular PathwaysT-cell and Retrovirus Studies

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes

Franza, B.Robert, Maruyama, Kazuo, Garrels, James I., Ruley, H.Earl·1986·Cell

DOI 10.1016/0092-8674(86)90462-9

Open this paper in CoChat — free account

Abstract

Activated ras genes transform REF52 cells only at low frequencies and adenovirus early region 1A collaborates with ras oncogenes to convert REF52 cells to a tumorigenic phenotype. While failure to transform did not result from an absence of ras gene expression, E1A appeared to enhance expression of transfected ras genes by approximately tenfold. However, enhanced ras expression alone does not account for collaboration by E1A since overexpression of T24 Ha-ras p21 induced morphological crisis and cell growth arrest rather than stable transformation. These results indicate that E1A contributes complementing biochemical activities that enable ras genes to transform REF52 and suggest that the role of E1A in primary cell transformation may extend beyond facilitating in vitro establishment.

Integrity signals

Registry

Crossref · 10.1016/0092-8674(86)90462-9

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
Southern, P. J., & Berg, P. R. (1982) · PubMed · Cited by 2,740
Transformation of mammalian cells with genes from procaryotes and eucaryotes
Wigler, M. H., Sweet, R. W., Sim, G.-K., Wold, B. J., Pellicer, À., Lacy, E., Maniatis, T., Silverstein, S. J., & Axel, R. (1979) · Cell · doi:10.1016/0092-8674(79)90093-x · Cited by 1,407
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene
Reddy, E. P., Reynolds, R. K., Santos, E., & Barbacid, M. (1982) · Nature · doi:10.1038/300149a0 · Cited by 1,391
Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture
Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Self-citation
Cellular Oncogenes and Multistep Carcinogenesis
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Science · doi:10.1126/science.6356358 · Cited by 1,111
In yeast, RAS proteins are controlling elements of adenylate cyclase
Toda, T., Uno, I., Ishikawa, T., Powers, S., Kataoka, T., Broek, D., Cameron, S., Broach, J. R., Matsumoto, K., & Wigler, M. H. (1985) · Cell · doi:10.1016/0092-8674(85)90305-8 · Cited by 1,108
Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue
Capon, D. J., Chen, E. Y., Levinson, A. D., Seeburg, P. H., & Goeddel, D. V. (1983) · Nature · doi:10.1038/302033a0 · Cited by 997
Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase.
Mulligan, R. C., & Berg, P. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 964

Show all 43 references

Research works printed but not linked: 1

Zerler, 1986, Analysis of adenovirus E1A coding sequences which enable ras and pmt oncogenes to transform cultured primary cells, Mol. Cell. Biol.

Sorted by citations

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling
Lin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945
ERK implication in cell cycle regulation
Chambard, J., LeFloch, R., Pouysségur, J., & Lenormand, P. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.010 · Cited by 749
Tumor surveillance via the ARF–p53 pathwayPreprint
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 718
Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis.Preprint
Lowe, S. W., & Ruley, H. E. (1993) · Genes & Development · doi:10.1101/gad.7.4.535 · Cited by 668
Self-citation
Oncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371
Myc and the cell cycle
Amati, B. B. (1998) · Frontiers in bioscience · doi:10.2741/a239 · Cited by 370
Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.
Wickstrom, E., Bacon, T. A., Gonzalez, A., Freeman, D. L., Lyman, G. H., & Wickstrom, E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1028 · Cited by 370
Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura, A., Cáceres, J. F., Mayeda, A., Franza, B. R., & Krainer, A. R. (1998) · PubMed Central · Cited by 329
Self-citation
Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells.
Lowe, S. W., Jacks, T., Housman, D. E., & Ruley, H. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2026 · Cited by 286
Self-citation
BRAFE600 in benign and malignant human tumours
Michaloglou, C., Vredeveld, L. C. W., Mooi, W. J., & Peeper, D. S. (2007) · Oncogene · doi:10.1038/sj.onc.1210704 · Cited by 278
Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice
Quaife, C. J., Pinkert, C. A., Ornitz, D. M., Palmiter, R. D., & Brinster, R. L. (1987) · Cell · doi:10.1016/0092-8674(87)90710-0 · Cited by 264
Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates
Rubin, H. (2001) · Carcinogenesis · doi:10.1093/carcin/22.12.1903 · Cited by 265
RAS pathways to cell cycle control and cell transformation
Pellicer, À. (1998) · Frontiers in bioscience · doi:10.2741/a331 · Cited by 251
Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice.
Andres, A. ‐., Schönenberger, C.-A., Groner, B., Hennighausen, L. G., LeMeur, M., & GERLINGER, P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1299 · Cited by 221
Ras‐mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.
Ridley, A. J., Paterson, H. F., Noble, M., & Land, H. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02990.x · Cited by 214
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human diseasePreprint
Wagner, M., Greten, F. R., Weber, C. K., Koschnick, S., Mattfeldt, T., Deppert, W., Kern, H. F., Adler, G., & Schmid, R. M. (2001) · Genes & Development · doi:10.1101/gad.184701 · Cited by 204
[40] Biological assays for Ras transformation
Clark, G. J., Cox, A. D., Graham, S. M., & Der, C. J. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(95)55042-9 · Cited by 197
Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence
Tang, Y., Horikawa, I., Ajiro, M., Robles, A. I., Fujita, K., Mondal, A. M., Stauffer, J. K., Zheng, Z.-M., & Harris, C. C. (2013) · Oncogene · doi:10.1038/onc.2012.288 · Cited by 165
Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs
Blalock, W. L., Oppenheimer, C. W., Chang, F., Hoyle, P., Wang, X. Y., Algate, P. A., Franklin, R. A., Oberhaus, S. M., Steelman, L. S., & McCubrey, J. A. (1999) · Leukemia · doi:10.1038/sj.leu.2401493 · Cited by 160
Senescence comes of age
Narita, M., & Lowe, S. W. (2005) · Nature Medicine · doi:10.1038/nm0905-920 · Cited by 153
The role of the H-ras oncogene in radiation resistance and metastasis
McKenna, W. G., Weiss, M. C., Bakanauskas, V. J., Sandler, H. M., Kelsten, M. L., Biaglow, J. E., Tuttle, S. W., Endlich, B., Ling, C. C., & Muschel, R. J. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90407-b · Cited by 145
An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells
Thangue, N. B. L., & Rigby, P. W. J. (1987) · Cell · doi:10.1016/0092-8674(87)90453-3 · Cited by 141
A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformationPreprint
Boiko, A. D., Porteous, S., Razorenova, O. V., Krivokrysenko, V. I., Williams, B. R. G., & Gudkov, A. V. (2006) · Genes & Development · doi:10.1101/gad.1372606 · Cited by 139
A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene
Cohen, J. B., & Levinson, A. D. (1988) · Nature · doi:10.1038/334119a0 · Cited by 133
Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.
Hirakawa, T., & Ruley, H. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1519 · Cited by 133
Self-citation
Cell cycle: Routine role for Ras
Downward, J. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00116-3 · Cited by 125
The Ras/Raf/MEK/Extracellular Signal-Regulated Kinase Pathway Induces Autocrine-Paracrine Growth Inhibition via the Leukemia Inhibitory Factor/JAK/STAT Pathway
Park, J., Strock, C. J., Ball, D. W., & Nelkin, B. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.543-554.2003 · Cited by 119
Synergy between the Mos/Mitogen-Activated Protein Kinase Pathway and Loss of p53 Function in Transformation and Chromosome Instability
Fukasawa, K., & Woude, G. F. V. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.506 · Cited by 117
The Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 125
A p53-dependent S-phase checkpoint helps to protect cells from DNA damage in response to starvation for pyrimidine nucleotides
Agarwal, M. L., Agarwal, A. M., Taylor, W. R., Chernova, O. B., Sharma, Y., & Stark, G. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14775 · Cited by 110
Growth-inhibitory Activity and Downregulation of the Class II Tumor-suppressor Gene H-rev107 in Tumor Cell Lines and Experimental Tumors
Sers, C., Emmenegger, U., Husmann, K., Bucher, K., Andres, A.-C., & Schäfer, R. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.4.935 · Cited by 107
Escape from premature senescence is not sufficient for oncogenic transformation by Ras
Peeper, D. S., Dannenberg, J., Douma, S., Riele, H. T., & Bernards, R. (2001) · Nature Cell Biology · doi:10.1038/35055110 · Cited by 104
Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence
Nakayama, Y., & Yamaguchi, N. (2013) · International review of cytology · doi:10.1016/b978-0-12-407695-2.00007-x · Cited by 101
Adenovirus early region 4 34-kilodalton protein directs the nuclear localization of the early region 1B 55-kilodalton protein in primate cells
Goodrum, F. D., Shenk, T. E., & Ornelles, D. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6323-6335.1996 · Cited by 100
Integration of positive and negative growth signals during ras pathway activation in vivo
Frame, S., & Balmain, A. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00052-0 · Cited by 96
[24] Biological assays for cellular transformation
Cox, A. D., & Der, C. J. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)38026-0 · Cited by 95
Transformation-sensitive and Growth-related Changes of Protein Synthesis in REF52 Cells
Garrels, J. I., & Franza, B. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83730-9 · Cited by 94
Self-citation
Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen
Zhu, J., Rice, P. W., Gorsch, L. C., Abate, M., & Cole, C. N. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2780-2791.1992 · Cited by 93
Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model
Adnane, J., Jackson, R. J., Nicosia, S. V., Cantor, A. B., Pledger, W. J., & Sebti, S. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203956 · Cited by 91
Interactions Between Cell Growth-Regulating Domains in the Products of the Adenovirus E1A Oncogene
Moran, B., & Zerler, B. R. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.4.1756 · Cited by 87
Ral-Specific Guanine Nucleotide Exchange Factor Activity Opposes Other Ras Effectors in PC12 Cells by Inhibiting Neurite Outgrowth
Goi, T., Rusanescu, G., Urano, T., & Feig, L. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1731 · Cited by 86
Immortalization by c- myc , H- ras , and Ela Oncogenes Induces Differential Cellular Gene Expression and Growth Factor Responses
Kelekar, A., & Cole, M. D. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.11.3899 · Cited by 81
p38MAPK in the Senescence of Human and Murine Fibroblasts
Debacq‐Chainiaux, F., Boilan, E., Moutier, J. D. L., Weemaels, G., & Toussaint, O. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7002-2_10 · Cited by 84
p53 in Tumor Progression: Life, Death, and Everything
Mowat, M. R. A. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60764-2 · Cited by 78
Expression of transfected mutant beta-actin genes: alterations of cell morphology and evidence for autoregulation in actin pools.
Leavitt, J. C., Ng, S. Y., Aebi, U., Varma, M., Latter, G. I., Burbeck, S., Kedes, L., & Gunning, P. W. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.7.2457 · Cited by 77
c-Myc Cooperates with Activated Ras To Induce the cdc2 Promoter
Born, T. L., Frost, J. A., Schönthal, A. H., Prendergast, G. C., & Feramisco, J. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5710 · Cited by 78
Cell Type-specific E2F Activation and Cell Cycle Progression Induced by the Oncogene Product Tax of Human T-cell Leukemia Virus Type I
Ohtani, K., Iwanaga, R., Arai, M., Huang, Y., Matsumura, Y., & Nakamura, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11154 · Cited by 76
Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis
Kim, Y. C., Song, K.-S., Yoon, G., Nam, M., & Ryu, W. (2001) · Oncogene · doi:10.1038/sj.onc.1203840 · Cited by 77
Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.
Hurlin, P. J., Maher, V. M., & McCormick, J. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.187 · Cited by 73
High-intensity Raf signals convert mitotic cell cycling into cellular growth.
Kerkhoff, E., & Rapp, U. R. (1998) · PubMed · Cited by 73
Cell Cycle Regulation of Histone H1 Kinase Activity Associated with the Adenoviral Protein E1A
Giordano, A., Lee, J. H., Scheppler, J. A., Herrmann, C. H., Harlow, E., Deuschle, U., Beach, D., & Franza, B. R. (1991) · Science · doi:10.1126/science.1653969 · Cited by 71
Self-citation
LMP1 of Epstein–Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression
Yang, X., He, Z., Xin, B., & Cao, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203515 · Cited by 71
Ras induces p21Cip1/Waf1 cyclin kinase inhibitor transcriptionally through Sp1-binding sites
Kivinen, L., Tsubari, M., Haapajärvi, T., Datto, M., Wang, X.-F., & Laiho, M. (1999) · Oncogene · doi:10.1038/sj.onc.1203000 · Cited by 68
Up-regulation of lysyl oxidase in spontaneous revertants of H-ras-transformed rat fibroblasts.
Hajnal, A., Klemenz, R., & Schäfer, R. (1993) · PubMed · Cited by 67
Suppression of apoptosis: role in cell growth and neoplasia
White, M. K., & McCubrey, J. A. (2001) · Leukemia · doi:10.1038/sj.leu.2402143 · Cited by 64
Escape from transforming growth factor beta control and oncogene cooperation in skin tumor development.
Missero, C., y Cajal, S. R., & Dotto, G. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9613 · Cited by 64
Mutant p53 Tumor Suppressor Alleles Release ras -Induced Cell Cycle Growth Arrest
Hicks, G. G., Egan, S. E., Greenberg, A. H., & Mowat, M. R. A. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1344 · Cited by 63
MYC Abrogates p53-Mediated Cell Cycle Arrest in N -(Phosphonacetyl)- l -Aspartate-Treated Cells, Permitting CAD Gene Amplification
Chernova, O. B., Chernov, M. V., Ishizaka, Y., Agarwal, M. L., & Stark, G. R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.536 · Cited by 62
Depletion of c- myc with Specific Antisense Sequences Reverses the Transformed Phenotype in ras Oncogene-Transformed NIH 3T3 Cells
Sklar, M. D., Thompson, E., Welsh, M. J., Liebert, M., Harney, J., Grossman, H. B., Smith, M. J., & Prochownik, E. V. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3699 · Cited by 60
Imaging of cortical astrocytes using 2-photon laser scanning microscopy in the intact mouse brain
Tian, G.-F., Takano, T., Lin, J. H.-C., Wang, X., Bekar, L. K., & Nedergaard, M. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.001 · Cited by 62
RACK1 Interacts with E1A and Rescues E1A-induced Yeast Growth Inhibition and Mammalian Cell Apoptosis
Sang, N., Severino, A., Russo, P., Baldi, A., Giordano, A., Mileo, A. M., Paggi, M. G., & Luca, A. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010346200 · Cited by 59
Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene
Greenhalgh, D. A., & Yuspa, S. H. (1988) · Molecular Carcinogenesis · doi:10.1002/mc.2940010209 · Cited by 58
Relation between the insulin receptor number in cells, autophosphorylation and insulin-stimulated Ras.GTP formation.
Osterop, A. P. R. M., Medema, R. H., Bos, J. L., van der Zon, G. C. M., Moller, D. E., Flier, J. S., Möller, W. J., & Maassen, J. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42090-x · Cited by 58
Partial reversion of the transformed phenotype in HRAS-transfected tumorigenic cells by transfer of a human gene.
Schaefer, R., Iyer, J., Iten, E., & Nirkko, A. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.5.1590 · Cited by 58
Cell-Dependent Efficiency of Reiterated Nuclear Signals in a Mutant Simian Virus 40 Oncoprotein Targeted to the Nucleus
Fischer-Fantuzzi, L., & Vesco, C. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.12.5495-5503.1988 · Cited by 56
Ha-RasG12V induces senescence in primary and immortalized human esophageal keratinocytes with p53 dysfunction
Takaoka, M., Harada, H., Deramaudt, T. B., Oyama, K., Andl, C. D., Johnstone, C. N., Rhoades, B., Enders, G. H., Opitz, O. G., & Nakagawa, H. (2004) · Oncogene · doi:10.1038/sj.onc.1207923 · Cited by 57
IFI16 Is an Essential Mediator of Growth Inhibition, but Not Differentiation, Induced by the Leukemia Inhibitory Factor/JAK/STAT Pathway in Medullary Thyroid Carcinoma Cells
Kim, E., Park, J., & Nelkin, B. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410542200 · Cited by 54
Ras versus cyclin-dependent kinase inhibitors
Lloyd, A. C. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80060-9 · Cited by 55
Adenovirus E1a ras Cooperation Activity Is Separate from Its Positive and Negative Transcription Regulatory Functions
Velcich, A., & Ziff, E. B. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.5.2177 · Cited by 53
Regulation of p53 expression by the RAS-MAP kinase pathway
Agarwal, M. L., Ramana, C. V., Hamilton, M., Taylor, W. R., DePrimo, S. E., Bean, L. J., Agarwal, A. M., Agarwal, M. K., Wolfman, A., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204353 · Cited by 52
The Molecular Scaffold Kinase Suppressor of Ras 1 Is a Modifier of Ras V12 -Induced and Replicative Senescence
Kortum, R. L., Johnson, H. J., Costanzo, D. L., Volle, D. J., Razidlo, G. L., Fusello, A. M., Shaw, A. S., & Lewis, R. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2202-2214.2006 · Cited by 55
The Activation of RalGDS Can Be Achieved Independently of Its Ras Binding Domain
Linnemann, T., Kiel, C., Herter, P., & Herrmann, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110800200 · Cited by 48
Interferon-Induced Revertants of ras-Transformed Cells: Resistance to Transformation by Specific Oncogenes and Retransformation by 5-Azacytidine
Samid, D., Flessate, D. M., & Friedman, R. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.6.2196 · Cited by 46
Overexpression of an Activated ras G Gene during Growth Blocks the Initiation of Dictyostelium Development
Khosla, M., Spiegelman, G. B., & Weeks, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4156 · Cited by 44
H-Ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinoma
Sathyan, K. M., Nalinakumari, K. R., & Kannan, S. (2007) · Modern Pathology · doi:10.1038/modpathol.3800948 · Cited by 43
Relationship between the transforming and transcriptional regulatory functions of adenovirus 2 E1a oncogene
Kuppuswamy, M. N., & Chinnadurai, G. (1987) · Virology · doi:10.1016/0042-6822(87)90344-8 · Cited by 41
Immortalization of primary epithelial cells requires first- and second-exon functions of adenovirus type 5 12S
Quinlan, M. P., & Douglas, J. L. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2020-2030.1992 · Cited by 41
p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints
Agapova, L. S., Ivanov, A., Sablina, A. A., Kopnin, P., Oi, S., Chumakov, P. M., & Kopnin, B. P. (1999) · Oncogene · doi:10.1038/sj.onc.1202386 · Cited by 40
Modulation of PI3K/Akt pathway by E1a mediates sensitivity to cisplatin
Viniegra, J. G., Hernández‐Losa, J., Lobo, V. J. S.-A., Cobo, C. P., Fernández‐Soria, V., y Cajal, S. R., & Sánchez‐Prieto, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205934 · Cited by 39
Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation
Carnero, A., & Beach, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207839 · Cited by 37
Aborting the birth of cancer
Venkitaraman, A. R. (2005) · Nature · doi:10.1038/434829a · Cited by 37
Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling
Joseph, T. W., Bryant, A., Frankel, P., Wooden, R., Kerkhoff, E., Rapp, U. R., & Foster, D. A. (2002) · Oncogene · doi:10.1038/sj.onc.1205380 · Cited by 37
Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors.
GARTE, S. J., Currie, D., & Troll, W. (1987) · PubMed · Cited by 36
The Role of Hypoxia Inducible Factor-1 Alpha in Bypassing Oncogene-Induced Senescence
Eren, M. K., & Tabor, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101064 · Cited by 35
Regulation of the p53 pathway by Ras, the plot thickens
McMahon, M., & Woods, D. B. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00027-5 · Cited by 35
Phosphorylation of serine residue 89 of human adenovirus E1A proteins is responsible for their characteristic electrophoretic mobility shifts, and its mutation affects biological function
Smith, C. S., Debouck, C. M., Rosenberg, M. J., & Culp, J. S. (1989) · Journal of Virology · doi:10.1128/jvi.63.4.1569-1577.1989 · Cited by 35
The Adenovirus Ela Gene Induces Differentiation of F9 Teratocarcinoma Cells
Montano, X., & Lane, D. P. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1782 · Cited by 33
Centrosome overduplication, increased ploidy and transformation in cells expressing endoplasmic reticulum-associated cyclin A2
Faivre, J., Frank-Vaillant, M., Poulhe, R., Mouly, H., Jessus, C., Bréchot, C., & Sobczak‐Thépot, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205215 · Cited by 31
Induction of telomerase activity in v-myc-transformed avian cells
Falchetti, M. L., Falcone, G., D’Ambrosio, E., Verna, R., Alemà, S., & Levi, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202438 · Cited by 28
Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification.
Perry, M. E., Commane, M., & Stark, G. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8112 · Cited by 28
Ras p21 in breast tissue: associations with pathology and cellular localisation
Going, J. J., Anderson, T., & Wyllie, A. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.9 · Cited by 27
Transformation of NIH 3T3 Cells by Cotransfection with c-src and Nuclear Oncogenes
Shalloway, D. I., Johnson, P. J., Freed, E. O., Coulter, D., & Flood, W. A. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.10.3582 · Cited by 26
Induction of cell death by stimulation of protein kinase C in human epithelial cells expressing a mutant ras oncogene: a potential therapeutic target
Hall-Jackson, C., Jones, T., Eccles, N., Dawson, T., BOND, J. A., Gescher, A. J., & Wynford‐Thomas, D. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.554 · Cited by 25
Gene expression profiling of fibroblasts resistant toward oncogene-mediated transformation reveals preferential transcription of negative growth regulators
Tchernitsa, O. I., Zuber, J. A., Sers, C., Brinckmann, R., Britsch, S. K., Adams, V., & Schäfer, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202987 · Cited by 24
A Swiss 3T3 Variant Cell Line Resistant to the Effects of Tumor Promoters Cannot Be Transformed by src
Nori, M., Shawver, L. K., & Weber, M. J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.8.4155 · Cited by 23
Recombinant human α2-HS glycoprotein inhibits insulin-stimulated mitogenic pathway without affecting metabolic signalling in Chinese hamster Ovary cells overexpressing the human insulin receptor
Srinivas, P. R., Deutsch, D. D., Mathews, S. T., Goustin, A. S., Leon, M. A., & Grunberger, G. (1996) · Cellular Signalling · doi:10.1016/s0898-6568(96)00110-6 · Cited by 22
Chronic NF-κB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response
Batsi, C., Markopoulou, S., Vartholomatos, G., Georgiou, I. A., Kanavaros, P., Gorgoulis, V. G., Marcu, K. B., & Kolettas, E. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.04.002 · Cited by 22

Authors: Franza, B. R., Maruyama, K., Garrels, J. I., & Ruley, H. E.
Affiliations: Cold Spring Harbor Laboratory (US)
Massachusetts Institute of Technology (US)
ORCID: Maruyama, Kazuo
Venue: Cell
Publisher: Elsevier BV
Published: 1986-02
Volume: 44
Issue: 3
Pages: 409-418
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/0092-8674(86)90462-9
OpenAlex: W2158195967
Cited by: 166
References: 43
Citations by year: 2024: 4 · 2023: 3 · 2022: 1 · 2021: 2 · 2019: 1 · 2017: 1 · 2016: 3 · 2014: 2 · 2013: 3 · 2012: 2
FWCI: 5.77
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: American Cancer Society
National Cancer Institute
Cancer Research Institute
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
Keywords: oncogenic Ras, adenovirus E1A, cell transformation, growth arrest, tumorigenicity, oncogene cooperation, in vitro establishment
MeSH terms: Adenoviridae, Cell Line, Cell Transformation, Neoplastic, Enhancer Elements, Genetic, Genes, Viral, Neoplasm Proteins, Oncogenes, Transfection, Proto-Oncogene Proteins p21(ras)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks